Form 4: BIO-key International: Insider Buys Shares

James David Sullivan, Chief Legal Officer and SVP Strategy & Compliance at BIO-key International, acquired 250 shares of common stock under an employee stock purchase plan.

Summary

• James David Sullivan, an officer of BIO-key International, Inc., acquired 250 shares of common stock on June 30, 2026.
• The acquisition was made through the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, as amended.
• This transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c).
• The purchase price was $3.83 per share.
• Following the transaction, Mr. Sullivan beneficially owns 9,986 shares.
• All share amounts reflect BIO-key's 1-for-10 reverse stock split, effective April 30, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider acquiring shares, which can signal confidence, but it is a routine transaction under an existing plan.

Positives

• Insider purchase of company stock indicates confidence from management.
• Acquisition made through an employee stock purchase plan, suggesting participation in company growth.
• Transaction is exempt from certain reporting requirements, indicating compliance with established plans.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which details a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider purchases, especially under employee stock plans, can be viewed positively by the market as they often signal a belief in the company's future prospects by those closest to its operations.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive signal of management's confidence in the company's value.
• Employees participating in the stock purchase plan are directly involved in the company's equity.

Key Dates

Keywords

BIO-key International, BKYI, Form 4, Insider Trading, Stock Purchase Plan, Common Stock, SEC Filing